Pharmaceuticals Singapore

Singapore Long-Read Sequencing Market Analysis, 2024–2034

Singapore Long-Read Sequencing Market Industry Trends and Forecast to 2034: Segmented by (Technology, Application, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Singapore · 2024–2034 · estimates

Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $1.4 Mn Estimated value
Estimate 2025 $1.7 Mn 0.1% of the global market
Projected 2034 $13.3 Mn 666.8% Adds $11.5 Mn over 9 forecast years
CAGR 2025–2034 25.4% Faster than 92% of 180 Pharmaceuticals markets here
Key players 5
  • Singapore is 0.11% of the global market.
  • In APAC, the largest is China at $122.8 Mn.
  • Fastest growing: India at 27.9% a year.
  • Singapore ranks 9th of 10 by size in APAC.

Market size projection

Singapore

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$11.5 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Long-Read Sequencing Market market size by year, Singapore
YearMarket sizeChange that yearSince 2025
2024 (estimate) $1.4 Mn — —
2025 (base) $1.7 Mn +$0.4 Mn —
2026 (forecast) $2.2 Mn +$0.4 Mn +25.4%
2027 (forecast) $2.7 Mn +$0.6 Mn +57.3%
2028 (forecast) $3.4 Mn +$0.7 Mn +97.2%
2029 (forecast) $4.3 Mn +$0.9 Mn +147.3%
2030 (forecast) $5.4 Mn +$1.1 Mn +210.1%
2031 (forecast) $6.7 Mn +$1.4 Mn +288.9%
2032 (forecast) $8.4 Mn +$1.7 Mn +387.6%
2033 (forecast) $10.6 Mn +$2.1 Mn +511.5%
2034 (forecast) $13.3 Mn +$2.7 Mn +666.8%

Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $1.56 Bn
  2. North America $801.0 Mn
  3. US $639.9 Mn
  4. APAC $329.2 Mn
  5. Europe $264.2 Mn
  6. Canada $124.0 Mn
  7. China $122.8 Mn
  8. Japan $103.1 Mn
  9. Latin America $60.8 Mn
  10. Middle East $58.3 Mn
  11. Germany $48.2 Mn
  12. Italy $41.9 Mn
  13. France $37.3 Mn
  14. UK $36.6 Mn
  15. Brazil $34.9 Mn
  16. Spain $30.7 Mn
  17. India $32.1 Mn
  18. Ecuador $30.3 Mn
  19. Saudi Arabia $28.5 Mn
  20. Africa $21.9 Mn
  21. Mexico $20.0 Mn
  22. New Zealand $17.1 Mn
  23. Russia $16.7 Mn
  24. Australia $16.5 Mn
  25. South Africa $9.4 Mn
  26. UAE $7.1 Mn
  27. Egypt $4.5 Mn
  28. Philippines $3.9 Mn
  29. Malaysia $2.8 Mn
  30. Hong Kong $2.2 Mn
  31. Singapore (this report) $1.7 Mn
  32. Thailand $1.7 Mn
  33. Kenya $1.1 Mn

The Singapore Long-Read Sequencing Market Analysis Executive Summary

Long-read sequencing reads long stretches of DNA in one go, finding complex genetic changes that short-read sequencing can miss.

Key segments of the long-Read Sequencing market include technology (Nanopore Sequencing and HiFi Sequencing) and application (Rare Disease, Structural Variants and Infectious Disease).

Singapore Long-Read Sequencing Market Dynamics

Market Growth Drivers

The falling cost of DNA sequencing, more targeted medicines, large national genome programmes and growing use of genetic results in everyday care are driving the long-Read Sequencing market.

Opportunity

Routine use of genomics in screening, pharmacy and primary care gives the long-Read Sequencing market large room to grow.

Market Restraints

Data privacy concerns, limited reimbursement for some tests, shortages of genetic counsellors and complex data analysis hold back the long-Read Sequencing market.

Competitive Landscape for Long-Read Sequencing Market in Singapore

The long-Read Sequencing market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Long-Read Sequencing Market in Singapore

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for long-Read Sequencing. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in Singapore.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Long-Read Sequencing right now, from free public sources.

Latest research 4,988 papers since 2021 (worldwide)

  1. The hidden burden of structural variants in neurodegenerative and neuromuscular disorders. Scientific reports, 2026
  2. The hidden genome of high-grade serous ovarian carcinoma: repetitive DNA, extrachromosomal DNA, and complex structural variation. Frontiers in molecular biosciences, 2026
  3. Evaluation of full-length 16S rRNA amplicon sequencing using Oxford Nanopore Technologies for diversity surveys of understudied microbiomes. Access microbiology, 2026
  4. Impact of rumen microbiome sample handling and extraction procedures on downstream long-read sequencing. Frontiers in cellular and infection microbiology, 2026
  5. The comprehensive detection of hemoglobinopathy variants via long-read sequencing. Human genomics, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Long-Read Sequencing in context

Singapore compared

  • Health spending per person: 3,922 US$ per person (2023). World: 1,317 US$ per person (2023). 3rd highest of the 15 countries we cover in APAC.[1]
  • Doctors: 2.83 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). 4th highest of the 15 countries we cover in APAC.[2]
  • People aged 65 and over: 14.2% of people (2025). World: 10.4% of people (2025). 7th highest of the 16 countries we cover in APAC.[3]

Questions, answered with public data

How much research is published on Long-Read Sequencing?
PubMed lists 4,988 papers added since January 2021 that match this market, worldwide.[4]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 13 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 13 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 13 Nov 2026.

[4] PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.

Free data on this topic

Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Long-Read Sequencing in Singapore? Our analysts can size it for your plan. Talk to us See the public data Health figures for every country, free. Open the Public Health Dashboard
Back to Catalogue
Keep exploring

Related Pharmaceuticals reports in Singapore

See all
Same topic, other categories

Related on genomics

See the topic